We have therefore inhibited TGF-β signalling using the ALK4/5/7 inhibitor SB431542 (Figure 5) and showed that hypoxia-induced enhanced NBC activation in MES-like hypoxia-dependent GBM cells is at least partly regulated by TGF-β signalling. Here, ACVR1B is linked to glioblastoma.